- Salary statistics
- Master of Science in Engineering, biotechnology drug development
Master of Science in Engineering, biotechnology drug development salary
38 900 - 64 500 kr / month
Women earn 92% of what men do.
Naturvetenskapligt arbete
Salary progression Master of Science in Engineering, biotechnology drug development
What does it mean to work as a Civil Engineer in Biotechnology and Pharmaceutical Development?
As a civil engineer in biotechnology and pharmaceutical development, you work in an exciting and dynamic environment where you combine scientific research with practical application. The job revolves around developing new drugs and biotechnological products, which means you can work in areas such as pharmacology and biomedicine. You participate in research projects, analyze biological data, and contribute to the development of new therapies and treatment methods.
Salary for a Civil Engineer in Biotechnology and Pharmaceutical Development
The average salary for a civil engineer in this field is 56 100 kronor per month. Men in the profession earn an average of 59200 kronor, while women earn 54 300 kronor. This means that women earn approximately 92% of what men do. The average hourly wage for an hourly employee is 337 kronor, based on 166 working hours per month.
It is also interesting to note that the average salary has decreased from 59 400 kronor to 56 100 kronor since the previous measurement. The highest salary in the profession is 64500 kronor, belonging to a man with a doctoral degree. For women, the highest salary is 60300 kronor. The lowest salary is 38900 kronor for women and 40800 kronor for men, both working in the public sector.
Educational Paths and Qualifications
To become a civil engineer in biotechnology and pharmaceutical development, a solid education is required. Typically, a career starts with a master's degree in biotechnology, biomedicine, or similar fields. The education includes courses in chemistry, biology, mathematics, and engineering. Many employers also value postgraduate education, which can open doors to more advanced positions in research and development.
Requirements for Employment
Establishing oneself in this profession requires not only a strong educational background but also experience and a network within the industry. Internships and research projects during the study period can be crucial for building experience and contacts. It is also advantageous to stay updated with the latest technological advancements and research findings in biotechnology and pharmaceutical development.
Working Conditions and Possible Benefits
The working conditions for civil engineers in biotechnology and pharmaceutical development vary depending on the employer. Many in this industry work in modern laboratories and research facilities. Benefits may include opportunities for further education, workplace flexibility such as the ability to work from home, and access to advanced technology and equipment.
Future Outlook and Challenges
The future outlook for civil engineers in biotechnology and pharmaceutical development is promising, although there is limited data for an exact forecast. Technological advancements and increasing investments in biotechnical research drive the demand for competent engineers in the field. Challenges include keeping up with rapid technological changes and navigating complex regulations in pharmaceutical development.
Competition in the Profession
While there is a strong demand for qualified civil engineers in biotechnology and pharmaceutical development, competition for the most attractive positions is fierce. Having a unique skill set or specialization can be a crucial factor in standing out in the job market.
In conclusion, the profession of civil engineering in biotechnology and pharmaceutical development offers an exciting career with opportunities for personal and professional growth. It is an industry with good prospects for the future, but it also requires a strong educational background and a willingness to adapt to constantly changing technologies and market conditions.
Salary distributed by age and sector
Age | Base salary | Monthly salary | |
---|---|---|---|
25-34 | 40400 kr | 40400 kr | |
35-44 | 54400 kr | 55000 kr | |
45-54 | 68000 kr | 68600 kr | |
55-64 | 57200 kr | 57700 kr | |
Snitt | 92% | 55700 kr | 56100 kr |
Age | Base salary | Monthly salary | |
---|---|---|---|
25-34 | 100% | 38300 kr | 38300 kr |
35-44 | 99% | 40500 kr | 40700 kr |
45-54 | 101% | 42700 kr | 42700 kr |
55-64 | 80% | 48400 kr | 48400 kr |
65-68 | 38900 kr | 38900 kr | |
Snitt | 95% | 42700 kr | 42800 kr |
Age | Base salary | Monthly salary | |
---|---|---|---|
25-34 | 100% | 38300 kr | 38300 kr |
35-44 | 99% | 40500 kr | 40700 kr |
45-54 | 101% | 42700 kr | 42700 kr |
55-64 | 80% | 48400 kr | 48400 kr |
65-68 | 38900 kr | 38900 kr | |
Snitt | 95% | 42700 kr | 42800 kr |
Age | Base salary | Monthly salary | |
---|---|---|---|
25-34 | 40500 kr | 40500 kr | |
35-44 | 55700 kr | 56400 kr | |
45-54 | 70300 kr | 71000 kr | |
Snitt | 91% | 56900 kr | 57400 kr |
Age | Base salary | Monthly salary | |
---|---|---|---|
25-34 | 40500 kr | 40500 kr | |
35-44 | 55700 kr | 56400 kr | |
45-54 | 70300 kr | 71000 kr | |
Snitt | 91% | 56900 kr | 57400 kr |
Age | Base salary | Monthly salary | |
---|---|---|---|
Snitt | 92% | 58800 kr | 59200 kr |
Age | Base salary | Monthly salary | |
---|---|---|---|
25-34 | 100% | 38300 kr | 38300 kr |
35-44 | 99% | 40900 kr | 40900 kr |
45-54 | 101% | 42500 kr | 42500 kr |
55-64 | 80% | 55200 kr | 55200 kr |
Snitt | 95% | 43900 kr | 43900 kr |
Age | Base salary | Monthly salary | |
---|---|---|---|
25-34 | 100% | 38300 kr | 38300 kr |
35-44 | 99% | 40900 kr | 40900 kr |
45-54 | 101% | 42500 kr | 42500 kr |
55-64 | 80% | 55200 kr | 55200 kr |
Snitt | 95% | 43900 kr | 43900 kr |
Age | Base salary | Monthly salary | |
---|---|---|---|
Snitt | 91% | 60500 kr | 60900 kr |
Age | Base salary | Monthly salary | |
---|---|---|---|
Snitt | 91% | 60500 kr | 60900 kr |
Age | Base salary | Monthly salary | |
---|---|---|---|
35-44 | 54400 kr | 55200 kr | |
45-54 | 63400 kr | 63500 kr | |
Snitt | 92% | 53700 kr | 54300 kr |
Age | Base salary | Monthly salary | |
---|---|---|---|
25-34 | 100% | 38400 kr | 38400 kr |
35-44 | 99% | 40200 kr | 40500 kr |
45-54 | 101% | 42900 kr | 43000 kr |
55-64 | 80% | 44300 kr | 44400 kr |
65-68 | 38900 kr | 38900 kr | |
Snitt | 95% | 41800 kr | 41800 kr |
Age | Base salary | Monthly salary | |
---|---|---|---|
25-34 | 100% | 38400 kr | 38400 kr |
35-44 | 99% | 40200 kr | 40500 kr |
45-54 | 101% | 42900 kr | 43000 kr |
55-64 | 80% | 44300 kr | 44400 kr |
65-68 | 38900 kr | 38900 kr | |
Snitt | 95% | 41800 kr | 41800 kr |
Age | Base salary | Monthly salary | |
---|---|---|---|
35-44 | 55300 kr | 56200 kr | |
45-54 | 64900 kr | 65100 kr | |
Snitt | 91% | 54800 kr | 55300 kr |
Age | Base salary | Monthly salary | |
---|---|---|---|
35-44 | 55300 kr | 56200 kr | |
45-54 | 64900 kr | 65100 kr | |
Snitt | 91% | 54800 kr | 55300 kr |
About the data
All information displayed on this page is based on data from the Swedish Central Bureau of Statistics (SCB), the Swedish Tax Agency and the Swedish employment agency. Learn more about our data and data sources here.
All figures are gross salaries, meaning salaries before tax. The average salary, or mean salary, is calculated by adding up the total salary for all individuals within the profession and dividing it by the number of individuals. For specific job categories, we have also considered various criteria such as experience and education.
Profession Master of Science in Engineering, biotechnology drug development has the SSYK code 2133, which we use to match against the SCB database to obtain the latest salary statistics.
-
Cell and molecular biologists etc.
-
Physicists and astronomers
-
Cell and molecular biologists etc.
-
Meteorologists
-
Environmental and health protection inspectors
-
Cell and molecular biologists etc.
-
Information about Statsskuld.se
Improvements on Statsskuld.se: News & Updates
Tue, 17 Dec 2024 - 08:56 -
Tax Pressure in Kiruna Municipality - An Overview of Tax Rates and Economic Challenges
Thu, 23 May 2024 - 22:26